Clinical Trials Logo

Clinical Trial Summary

This is a randomized trial of patients with gastrointestinal (GI) cancers treated at University of California, San Francisco (UCSF) who are starting a new line of systemic therapy to evaluate the feasibility of electronic patient reported outcome (ePRO) platform.


Clinical Trial Description

PRIMARY OBJECTIVES: I. To evaluate the feasibility of the ePRO platform by describing the proportion of participants who engage with the ePRO tool via virtual care chat at least once after enrollment. II. To investigate the potential differences in health-related quality of life (HRQoL) by comparing the change in overall score of EuroQol five-dimensional Questionnaire (EQ-5D) index. SECONDARY OBJECTIVES: I. To evaluate the degree of engagement with virtual care chat as defined by the proportion of chat modules completed. II. To measure the potential differences in health-related quality of life (HRQoL). III. To describe the symptom experience of participants in the intervention arm. IV. To evaluate the performance of clinical escalation rules and impact on clinic workflow and efficiency. V. To prospectively validate a risk model predicting emergency department (ED) visits and admissions due to cancer treatment side effects. EXPLORATORY OBJECTIVES: I. To compare unplanned ED visits and hospitalizations between intervention arm and control arm. II. To compare referral patterns to Symptom Management Clinic. III. To compare concordance between participant self-reported and provider assigned Eastern Cooperative Oncology Group (ECOG) Performance Status. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05359042
Study type Interventional
Source University of California, San Francisco
Contact
Status Withdrawn
Phase N/A
Start date June 15, 2024
Completion date December 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02349958 - Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy Phase 2
Completed NCT00585637 - Vitamin D for Chemoprevention Phase 1
Recruiting NCT04724070 - PRecision Oncology CUhk pRogrammE (PRO-CURE)
Terminated NCT02005614 - A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection N/A
Completed NCT00364078 - Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care N/A
Terminated NCT03407040 - Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
Completed NCT02045368 - Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R Phase 1
Completed NCT01200121 - Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers Phase 2
Recruiting NCT02013089 - A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study N/A
Recruiting NCT05641896 - Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers Phase 2